These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 1474432

  • 1. Investigational trends: clean room environmental monitoring.
    Tetzlaff RF.
    J Parenter Sci Technol; 1992; 46(6):206-14. PubMed ID: 1474432
    [Abstract] [Full Text] [Related]

  • 2. Validation of environmental monitoring methods and levels.
    Noble NH.
    J Parenter Sci Technol; 1993; 47(1):26-8. PubMed ID: 8445496
    [Abstract] [Full Text] [Related]

  • 3. PDA presentation at FDA Open Conference on Sterile Drug Manufacturing. Parenteral Drug Association.
    J Pharm Sci Technol; 1994; 48(1):4-6. PubMed ID: 8004417
    [No Abstract] [Full Text] [Related]

  • 4. Preparing for an FDA preapproval inspection.
    Blackmer RA.
    Qual Assur; 1994 Dec; 3(4):389-403. PubMed ID: 7613749
    [Abstract] [Full Text] [Related]

  • 5. An FDA update on GMP's for aseptic processing.
    Fry EM.
    J Parenter Sci Technol; 1985 Dec; 39(4):154-7. PubMed ID: 3928863
    [No Abstract] [Full Text] [Related]

  • 6. A review of current technology in parenteral manufacturing.
    Akers JE, Agalloco JP, Carleton FJ, Korczynski MS.
    J Parenter Sci Technol; 1988 Dec; 42(2):53-6. PubMed ID: 3385542
    [No Abstract] [Full Text] [Related]

  • 7. Parenteral Drug Association response to FDA proposal to prohibit the use of any antimicrobial preservative in single-dose parenteral drug products.
    J Parenter Sci Technol; 1985 Dec; 39(6):231-2. PubMed ID: 4093824
    [No Abstract] [Full Text] [Related]

  • 8. Ten steps to ensure a successful preNDA approval inspection.
    Justice RM, Rodriguez JO, Chiasson WJ.
    J Parenter Sci Technol; 1993 Dec; 47(2):89-92. PubMed ID: 8515350
    [Abstract] [Full Text] [Related]

  • 9. Current regulatory issues regarding parenteral inspections.
    Avallone H.
    J Parenter Sci Technol; 1989 Dec; 43(1):3-7. PubMed ID: 2926605
    [No Abstract] [Full Text] [Related]

  • 10. Good validation practices: FDA issues.
    Levchuk JW.
    PDA J Pharm Sci Technol; 1994 Dec; 48(5):221-3. PubMed ID: 8000894
    [No Abstract] [Full Text] [Related]

  • 11. Environmental monitoring programs vs Good Laboratory Practice (GLP) programs: differences and similarities.
    Bentley RE.
    Qual Assur; 1995 Dec; 4(4):283-7. PubMed ID: 8890354
    [Abstract] [Full Text] [Related]

  • 12. New drug applications; drug master files. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Jan 12; 65(8):1776-80. PubMed ID: 11010656
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Getting SMART (submission management and review tracking) drug review in the computer age.
    Flieger K.
    FDA Consum; 1995 Oct 12; 29(8):6-9. PubMed ID: 10151839
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Current regulatory issues regarding sterile products.
    Avallone H.
    J Parenter Sci Technol; 1990 Oct 12; 44(4):228-30. PubMed ID: 2213432
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Development and approval of vaccines in the United States.
    Botstein P.
    Isr J Med Sci; 1986 Oct 12; 22(3-4):268-71. PubMed ID: 3528047
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.